Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.

CSE:BRAX - Post by User

Braxia Scientific Corp

<< Previous

Bullboard Posts

Next >>

Post by Recontrader1976on Nov 23, 2020 9:46am

929 Views

Post# 31951515

SHRM emailed me back finally....

Well SHRM finally emailed me back.. This was kinda what I was expecting but at least they finally got back to me. Will hold for now. Hopefully they can get their Sh*t together and trade in the near future. GLTA holding.

Thank you for your inquiry. We apologize for the delayed response. The Company continues to work with the British Columbia Securities Commission to address the ongoing continuous disclosure review and is confident that the review will be resolved soon.

As soon as the Cease Trade Order (CTO) has been lifted we will share an update.

In the interim, we have:

Added a Frequently Asked Questions page to our website.
On November 10 issued a news release on CRTCE opening a second location: https://www.newswire.ca/news-releases/canadian-rapid-treatment-center-of-excellence-opens-second-location-providing-ketamine-treatment-for-adults-with-depression-869677187.html
On October 29 issued a news release on the CTO: https://www.newswire.ca/news-releases/champignon-brands-provides-update-on-continuous-disclosure-review-894621505.html
On October 5 announced the election of Dr. Roger McIntyre as the new Board Chair: https://www.newswire.ca/news-releases/dr-roger-mcintyre-elected-board-chair-of-champignon-brands-inc--823764635.html

You may be interested in viewing the October 1 presentation by Dr. Roger McIntyre. Here is the link https://champignonbrands.com/wp-content/uploads/2020/10/SHRM.mp4.

Thank you for your interest.

Champignon Brands Inc.

<< Previous

Bullboard Posts

Next >>

Theralase enhances cancer drug efficacy